Recordati Ilac Company Profile: Acquisition & Investors | PitchBook
ANNUAL REPORT 2013
RECORDATI: BOARD APPROVES THE 2011 ACCOUNTS. REVENUE € 762.0 MILLION (+4.7%), OPERATING INCOME € 1
Recordati S.p.A - About Us > History
ANNUAL REPORT 2012
A European Specialty Pharmaceutical Group
growth
RECORDATİ SÜSPANSİYON HATTINA YATIRIM YAPTI
PATIENTS | PEOPLE | PRODUCTS | PERFORMANCE
INTERIM REPORT FIRST NINE MONTHS 2013
Untitled
RECORDATI: VERY GOOD FIRST HALF 2011 RESULTS. SALES +6.6%. NET INCOME +5.3%
RECORDATI: VERY GOOD FIRST NINE MONTHS 2011 RESULTS. SALES +5.8%. NET INCOME +5.8%. INTERIM DIVIDEND DI
Recordati acquires AstraZeneca blood pressure brands - PMLiVE
CFA Institute Research Challenge
PATIENTS | PEOPLE | PRODUCTS | PERFORMANCE
Untitled
Recordati S.p.A - About Us > History
RECORDATI FINALIZES ITS ACQUISITION OF FRIK İLAÇ IN TURKEY
Медицинские препараты Recordati Ilac Стамбул, Турция
İş Girişim | Frik İlaç
RECORDATI FINALIZES ITS ACQUISITION OF FRIK İLAÇ IN TURKEY
Медицинские препараты Recordati Ilac Стамбул, Турция
